CUDC-907 mesylate
CUDC-907 mesylate is a dual inhibitor of HDAC and PI3K developed by Curis. It is being clinically evaluated for various relapsed or refractory cancers, including lymphomas and solid tumors. Preclinical studies demonstrate its activity in inducing apoptosis and inhibiting tumor growth in both cellular and animal models.
Product Specifications
CAS Number
1401998-36-4
Field of Research
Cell Biology, Epigenetics & Chromatin, Molecular Biology, Signal Transduction
Smiles
CS (O) (=O) =O.COc1ccc (cn1) -c1nc (N2CCOCC2) c2sc (CN (C) c3ncc (cn3) C (=O) NO) cc2n1
Molecular Formula
C24H28N8O7S2
Molecular Weight
604.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
130358 50 µg
NHLH1 (BHLHA35, HEN1, Helix-loop-helix Protein 1, Class A Basic Helix-loop-helix Protein 35, Nescient Helix Loop Helix 1)
Sign In for Pricing
View Details 
orb3171600-01 1 mg
3,6a,7,12-tetrahydroxy-8-methoxy-3-methyl-1,2,3,4,6a,7,12,12a-octahydrotetraphen-1-one
Sign In for Pricing
View Details orb3171600-02 2 mg
3,6a,7,12-tetrahydroxy-8-methoxy-3-methyl-1,2,3,4,6a,7,12,12a-octahydrotetraphen-1-one
Sign In for Pricing
View Details orb3171600-03 3 mg
3,6a,7,12-tetrahydroxy-8-methoxy-3-methyl-1,2,3,4,6a,7,12,12a-octahydrotetraphen-1-one
Sign In for Pricing
View Details orb3171600-04 4 mg
3,6a,7,12-tetrahydroxy-8-methoxy-3-methyl-1,2,3,4,6a,7,12,12a-octahydrotetraphen-1-one
Sign In for Pricing
View Details